Myeloablative conditioning predisposes patients for toxoplasma gondii reactivation after allogeneic stem cell transplantation

Clinical Infectious Diseases

Volumn 50, Issue 8, 2010, Pages 1127-1134

  Meers, Stef ^a   Lagrou, Katrien ^a   Theunissen, Koen ^a   Dierickx, Daan ^a   Delforge, Michel ^a   Devos, Timothy ^a   Janssens, Ann ^a   Meersseman, Wouter ^a   Verhoef, Gregor ^a   Van Eldere, Johan ^a   Maertens, Johan ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; IMMUNOGLOBULIN G; PYRIMETHAMINE;

ADOLESCENT; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CHILD; DISEASE DURATION; DISEASE PREDISPOSITION; FEASIBILITY STUDY; FEMALE; HUMAN; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNOGLOBULIN BLOOD LEVEL; INCIDENCE; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MICROORGANISM DETECTION; MYELOABLATIVE CONDITIONING; NONHUMAN; OUTCOME ASSESSMENT; PATIENT MONITORING; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; TOXOPLASMA GONDII; TOXOPLASMOSIS; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; AGED; ANIMALS; BLOOD; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; INCIDENCE; INFANT; MALE; MIDDLE AGED; MYELOABLATIVE AGONISTS; OPPORTUNISTIC INFECTIONS; POLYMERASE CHAIN REACTION; STEM CELL TRANSPLANTATION; TOXOPLASMA; TOXOPLASMOSIS; WHOLE-BODY IRRADIATION; YOUNG ADULT;

EID: 77950262232     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/651266     Document Type: Article

References (23)

1. Hill DE, Chirukandoth S, Dubey JP. Biology and epidemiology of Toxoplasma gondii in man and animals. Anim Health Res Rev 2005; 6: 41-61.
2. Slavin MA, Meyers JD, Remington JS, Hackman RC. Toxoplasma gondii infection in marrow transplant recipients: a 20 year experience. Bone Marrow Transplant 1994; 13: 549-557.
3. Martino R, Bretagne S, Einsele H, et al. Early detection of Toxoplasma infection by molecular monitoring of Toxoplasma gondii in peripheral blood samples after allogeneic stem cell transplantation. Clin Infect Dis 2005; 40: 67-78.
4. Sullivan KM, Dykewicz CA, Longworth DL, et al. Preventing opportunistic infections after hematopoietic stem cell transplantation: The Centers for Disease Control and Prevention, Infectious Diseases Society of America, and American Society for Blood and Marrow Transplantation Practice Guidelines and Beyond. Hematology Am Soc Hematol Educ Program 2001; 2001: 392-421.
5. Bretagne S, Costa JM, Poulet F, Jabot-Lestang L, Baud-Camus F, Cordonnier C. Prospective study of toxoplasma reactivation by polymerase chain reaction in allogeneic stem-cell transplant recipients. Transpl Infect Dis 2000; 2: 127-132.
6. Kupferschmidt O, Kruger D, Held TK, Ellerbrok H, Siegert W, Janitschke K. Quantitative detection of Toxoplasma gondii DNA in human body fluids by TaqMan polymerase chain reaction. Clin Microbiol Infect 2001; 7: 120-124.
7. Martino R, Maertens J, Bretagne S, et al. Toxoplasmosis after hematopoietic stem cell transplantation. Clin Infect Dis 2000; 31: 1188-1195.
8. Klein JP, Andersen PK. Regression modeling of competing risks data based on pseudovalues of the cumulative incidence function. Biometrics 2005; 61: 223-229.
9. de Medeiros BC, de Medeiros CR, Werner B, Loddo G, Pasquim R, Bleggi-Torres LF. Disseminated toxoplasmosis after bone marrow transplantation: report of 9 cases. Transpl Infect Dis 2001; 3: 24-28.
10. Mele A, Paterson PJ, Prentice HG, Leoni P, Kibbler CC. Toxoplasmosis in bone marrow transplantation: a report of two cases and systematic review of the literature. Bone Marrow Transplant 2002; 29: 691-698.
11. Roemer E, Blau IW, Basara N, et al. Toxoplasmosis, a severe complication in allogeneic hematopoietic stem cell transplantation: successful treatment strategies during a 5-year single-center experience. Clin Infect Dis 2001; 32:E1-8.
12. Martino R, Bretagne S, Rovira M, et al. Toxoplasmosis after hematopoietic stem transplantation: report of a 5-year survey from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 2000; 25: 1111-1114.
13. Derouin F, Pelloux H. Prevention of toxoplasmosis in transplant patients. Clin Microbiol Infect 2008; 14: 1089-1101.
14. Small TN, Leung L, Stiles J, et al. Disseminated toxoplasmosis following T cell-depleted related and unrelated bone marrow transplantation. Bone Marrow Transplant 2000; 25: 969-973.
15. Belanger F, Derouin F, Grangeot-Keros L, Meyer L. Incidence and risk factors of toxoplasmosis in a cohort of human immunodeficiency virusinfected patients: 1988-1995. HEMOCO and SEROCO Study Groups. Clin Infect Dis 1999; 28: 575-581.
16. Derouin F, Devergie A, Auber P, et al. Toxoplasmosis in bone marrowtransplant recipients: report of seven cases and review. Clin Infect Dis 1992; 15: 267-270.
17. Chandrasekar PH, Momin F. Disseminated toxoplasmosis in marrow recipients: a report of three cases and a review of the literature. Bone Marrow Transplant Team. Bone Marrow Transplant 1997; 19: 685-689.
18. Lebech M, Lebech AM, Nclsing S, Vuust J, Mathiescn L, Petersen E. Detection of Toxoplasma gondii DNA by polymerase chain reaction in cerebrospinal fluid from. AIDS patients with cerebral toxoplasmosis. J Infect Dis 1992; 165: 982-983.
19. Bretagne S. Molecular diagnostics in clinical parasitology and mycology: limits of the current polymerase chain reaction (PCR) assays and interest of the real-time PCR assays. Clin Microbiol Infect 2003; 9: 505-511.
20. Pelloux H, Guy E, Angelici MC, et al. A second European collaborative study on polymerase chain reaction for Toxoplasma gondii, involving 15 teams. FEMS Microbiol Lett 1998; 165: 231-237.
21. Ellis JT. Polymerase chain reaction approaches for the detection of Neospora caninum and Toxoplasma gondii. Int J Parasitol 1998; 28: 1053-1060.
22. Ribera E, Fernandez-Sola A, Juste C, et al. Comparison of high and low doses of trimethoprim-sulfamethoxazole for primary prevention of toxoplasmic encephalitis in human immunodeficiency virus-infected patients. Clin Infect Dis 1999; 29: 1461-1466.
23. Carr A, Tindall B, Brew BJ, et al. Low-dose trimethoprim-sulfameth- oxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS. Ann Intern Med 1992; 117: 106-111.